Catheterization and Cardiovascular Interventions

Coronary Artery Disease

A Case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors

Corresponding Author

Manmeet Singh MD

Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno, Fresno, California

Correspondence to: Manmeet Singh, Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno,155th N Fresno Street, Fresno, CA-93711. E-mail: [email protected] and [email protected]Search for more papers by this author

Vema H. Bolla MD,

Vema H. Bolla MD

Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno, Fresno, California

Search for more papers by this author

Ryan Berg MD,

Ryan Berg MD

Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno, Fresno, California

Search for more papers by this author

Manmeet Singh MD,

Corresponding Author

Manmeet Singh MD

Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno, Fresno, California

Vema H. Bolla MD,

Vema H. Bolla MD

Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno, Fresno, California

Search for more papers by this author

Ryan Berg MD,

Ryan Berg MD

Division Cardiology, Department of Internal Medicine, University of California San Francisco, MEP Fresno, Fresno, California

Search for more papers by this author

First published: 04 February 2013

https://doi.org/10.1002/ccd.24845

Citations: 1

Conflict of interest: Nothing to report.

Share a link

Email
Wechat
Bluesky

Abstract

The management of patients with drug eluting stents (DES) who require early surgical intervention prior to the completion of antiplatelet therapy is challenging. Available literature suggests that bridging these high risk patients with glycoprotein IIb/IIIa (g2b3a) inhibitors could be efficacious in preventing stent thrombosis (Ben Morrison et al., Catheter Cardiovasc Interv 2012;79;575–582). However, this still remains to be proven in larger prospective studies. We report a case of stent thrombosis in a patient with DES planned for neurosurgery while on bridging g2b3a inhibitors therapy in the perioperative period. © 2013 Wiley Periodicals, Inc.

REFERENCES

1 Ben Morrison T, Horst BM, Brown MJ, Bell MR, Daniels PR. Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents. Catheter Cardiovasc Interv 2012; 79; 575–582.
10.1002/ccd.23172
PubMed Web of Science® Google Scholar
2 Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 2010; 3: 131–142.
10.1016/j.jcin.2009.11.017
PubMed Web of Science® Google Scholar
3 Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50: 1707–1732.
10.1016/j.jacc.2007.09.001
PubMed Web of Science® Google Scholar
4 American Heart Association. Heart Disease and Stroke Statistics: 2009 Update At-a-Glance. Dallas, Texas: American Heart Association; 2009.
Web of Science® Google Scholar
5 Kushner FG, Hand M, Smith SC Jr, King SB III, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Catheter Cardiovasc Interv 2009; 74: E25–E68.
10.1002/ccd.22351
PubMed Google Scholar
6 Burzotta F, Parma A, Pristipino C, Manzoli A, Belloni F, Sardella G, Rigattieri S, Danesi A, Mazzarotto P, Summaria F, et al. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: The OPTIMIST study. Eur Heart J 2008; 29: 3011–3021.
10.1093/eurheartj/ehn479
PubMed Web of Science® Google Scholar
7 Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947–953.
10.1016/j.jacc.2004.09.079
CAS PubMed Web of Science® Google Scholar
8 Alshawabkeh L, Prasad A, Lenkovsky F, Kandil E, Weideman R, Kelly K, Rangan B, Banerjee S, Brilakis E. Outcomes of a preoperative bridging strategy with glycoprotein 2b/3a inhibitors for preventing perioperative stent thrombosis in patients with drug eluting stents who undergoes surgery necessitating interruption of thienopyridine administration. J Am Coll Cardiol 2012; 59(13s1): E502–E502.
10.1016/S0735-1097(12)60503-8
Google Scholar
9 Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention—Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—Review and meta-analysis. J Intern Med 2005; 257: 399–414.
10.1111/j.1365-2796.2005.01477.x
CAS PubMed Web of Science® Google Scholar
10 Honda Y, Fitzerald PJ. Stent thrombosis: An issue revisited in a changing world circulation 2003; 108: 2–5.
10.1161/01.CIR.0000075929.79964.D8
PubMed Web of Science® Google Scholar
11 Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, Voeltz MD, Chandna H, Ramaiah C, Brtko M, Cannon L, Dyke C, Liu T, Montalescot G, Manoukian SV, Prats J, Topol EJ; BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial. JAMA 2012; 307: 265–274.
10.1001/jama.2011.2002
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume82, Issue7

1 December 2013

Pages 1108-1112

SCAI Member Sign in

A Case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

A Case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors

Abstract

REFERENCES

Citing Literature

References

Related

Information